Market Exclusive

AbbVie Inc. (NYSE:ABBV) reported earnings of $1.42 per share beating Walls Streets expectations.

AbbVie Inc. (NYSE:ABBV) reported Q2 2017 earnings this Morning, coming in at $1.42 per share, beating Wall Street’s estimates of $1.40 per Share. Revenue for the quarter came in at $6.94 billion beating analyst estimates of $6.93 billion

Analyst Coverage For AbbVie Inc. (NYSE:ABBV)
These are 7 Hold Ratings, 5 Buy Ratings, 1 Strong Buy Rating .
The current consensus rating for AbbVie Inc. (NYSE:ABBV) is Buy (Score: 2.54) with a consensus target price of $74.58 , a potential (3.98% upside)Recent Insider Trading for AbbVie Inc. (NYSE:ABBV)

Dividend History for AbbVie Inc. (NYSE:ABBV)

Recent Trading for AbbVie Inc. (NYSE:ABBV) Shares of AbbVie Inc. closed the previous trading session at 70.31 down -1.42 -1.98% with 7,389,286 shares trading hands.

Exit mobile version